
U.S. Naloxone Market Projected To Witness Massive Growth, 2025-2032 | Adapt Pharma, Mylan N.V., Hospira Inc (Pfizer Inc)
BURLINGAME, CA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The U.S. Naloxone Market represents a critical segment within the emergency medical treatment industry, driven by escalating opioid overdose incidents and evolving public …